bèta
Trial Radar AI

Er worden klinische studies passend bij locatie: China getoond.

Ik help u graag met het vinden van klinische studies op specifieke locaties en bied waardevolle inzichten in gezondheidsaandoeningen en behandelingen.

Met de geavanceerde modus krijgt u toegang tot krachtige pre-screeningtools, interactieve visualisaties en gepersonaliseerde e-mailmeldingen voor studie-updates.

Onze zoekfunctie ondersteunt alleen Engels. Gebruik de Trial Radar AI hierboven om te zoeken en te discussiëren in andere talen, of selecteer hieronder de filters voor aandoening en locatie.
3.416 resultaten
Toont de 50 beste
 
Status (Standaard)
Nog Niet Rekruterend, Rekruterend, Actief, Niet Rekruterend
×
 
Locatie
China
×
 
Geslacht
Vrouw
×
 
Fase
Fase 2
×
 
Studietitel
Status
Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma (LUXUS41) NCT07498907
Nog niet rekruterend
A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer NCT07497386
Nog niet rekruterend
JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer NCT07497074
Nog niet rekruterend
Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3) NCT07496229
Nog niet rekruterend
A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease. (Negentropy) NCT07496177
Nog niet rekruterend
cfMSC Therapy for Diabetes NCT07495956
Rekruterend
A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection NCT07495215
Rekruterend
Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL NCT07494565
Nog niet rekruterend
Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC NCT07494435
Nog niet rekruterend
Clinical Study on the Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Nab-Paclitaxel in Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma NCT07493993
Nog niet rekruterend
Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients NCT07493980
Nog niet rekruterend
Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL NCT07493148
Rekruterend
A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma NCT07493135
Nog niet rekruterend
Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma NCT07492914
Nog niet rekruterend
Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors NCT07492693
Rekruterend
A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma NCT07492615
Rekruterend
Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer NCT07492394
Rekruterend
Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC (K-NADIR) NCT07492342
Rekruterend
Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized Trial NCT07492225
Actief, niet rekruterend
Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial NCT07491783
Nog niet rekruterend
Fruquintinib Plus Checkpoint Inhibitor Combined or Sequential TAS-102 in Colorectal Cancer Patients Who Progressed on Second-line Standard Therapy: a Prospective, Multi-cohort, Single-centered, Phase Ib/II Study NCT07491159
Actief, niet rekruterend
Phase II Clinical Study of the Efficacy and Safety of HSK55718 in the Treatment of Abdominal Postoperative Pain NCT07491146
Nog niet rekruterend
To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Allergy and Immune Function in Infants NCT07490587
Rekruterend
A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment. NCT07490262
Nog niet rekruterend
Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer (OMPC-RPM) NCT07490210
Nog niet rekruterend
Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination. NCT07489989
Rekruterend
Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction NCT07489534
Rekruterend
A Dose-exploration Study of EDP167 in HoFH NCT07489209
Rekruterend
A Phase 2 Safety and Efficacy Study Evaluating CS-101 in Participants With β-Thalassemia Major NCT07489196
Nog niet rekruterend
Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia NCT07486726
Nog niet rekruterend
Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib (Precision) NCT07486648
Nog niet rekruterend
Evaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC in Patients With Advanced Gastric Cancer and PeritonealMetastasis: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial NCT07486310
Nog niet rekruterend
A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression NCT07485595
Nog niet rekruterend
A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma NCT07484724
Nog niet rekruterend
Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients NCT07483671
Nog niet rekruterend
IBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of Resectable, Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma NCT07483567
Nog niet rekruterend
IBI343 in Combination Therapy for Advanced Malignant Solid Tumors NCT07483554
Nog niet rekruterend
Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus (CONV3RSION) NCT07483359
Nog niet rekruterend
A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma NCT07482059
Rekruterend
SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism NCT07482020
Rekruterend
Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) (TESA-LIVER) NCT07481734
Rekruterend
ASCT With TEAM Conditioning for Lymphoma With High Risk of CNS Relapse NCT07481669
Rekruterend
KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer NCT07481058
Rekruterend
Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) (DUAL-OV-CAR-NK) NCT07480954
Rekruterend
Treatment of BTKi+Hi-CVP Regimen for Previously Untreated MZL NCT07480863
Actief, niet rekruterend
Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell Lymphoma NCT07480850
Actief, niet rekruterend
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors NCT07480733
Nog niet rekruterend
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma NCT07479732
Rekruterend
MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II) NCT07479485
Nog niet rekruterend
Neoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer (MA-CRC-II-018) NCT07478731
Rekruterend